Fred Lam, MD
Hometown: Baltimore, MD
Medical School: East Tennessee State University James H. Quillen College of Medicine
Residency: Johns Hopkins Hospital
Hometown: Baltimore, MD
Medical School: East Tennessee State University James H. Quillen College of Medicine
Residency: Johns Hopkins Hospital
Catherine is a Lexington, KY native and completed her undergraduate degree at Centre College prior to attending medical school at the University of Kentucky. She then completed an Internal Medicine-Pediatric residency at Vanderbilt University Medical Center followed by a year as the first Medicine-Pediatrics chief resident in 2021-2022. Following her chief year, Dr. Deffendall began her combined adult and pediatric Rheumatology fellowship.
During fellowship, she gained an appreciation for quality improvement research and began a Masters in Public Health in 2024 with the goal of improving care for Rheumatology patients. Her clinical interests are in transitions of care, reproductive health in rheumatic diseases, and systemic lupus erythematosus.
Residency: Internal Medicine-Pediatrics, Vanderbilt University Medical Center, 2021
Medical School: University of Kentucky
Undergraduate: Centre College
Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus, Musculoskeletal Pain, Mental Health
B.S.N.
Vanderbilt University
M.S.N.
Vanderbilt University School of Nursing
D.N.P.
George Washington University
Dr. Smith is a pediatric cardiac intensivist whose academic efforts focus upon understanding and improving outcomes for children following congenital heart surgery. Specifically, his interests include the application of supervised machine learning approaches to better appreciate modifiable risk factors associated with postoperative clinical outcomes, understanding and mitigating the cognitive burden associated with interruptive alerts in an intensive care unit environment, and leveraging clinical registry experience to explore linkages between large administrative and clinical datasets to better understand resource demands associated with high-quality care. For over 15 years, he has also pursued his interest in personalized medicine by exploring the role of genetic variants and their contribution to postoperative outcomes commonly encountered in the cardiac intensive care unit.
Pediatric cardiac critical care, mechanical circulatory support, early postoperative arrhythmias
M.D.
University of Maryland School of Medicine, Baltimore, MD (2001)
M.S.C.I.
Vanderbilt University School of Medicine, Nashville, TN (2007)
M.M.H.C.
Vanderbilt University Owen Graduate School of Management, Nashville, TN (2012)
Residency
Pediatrics - Vanderbilt University Medical Center/Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN (2004)
Fellowships
Pediatric Cardiology - Vanderbilt University Medical Center/Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN (2007)
Pediatric Critical Care Medicine - Vanderbilt University Medical Center/Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN (2009)
Senior Clinical Fellowship, Cardiac Critical Care Medicine - Children's Hospital Boston, Boston, MA (2009)
Child & Adolescent Psychology, Behavioral Health in Primary Care
Ph.D.
Clinical Psychology - Vanderbilt University
Clinical Internship
University of Wisconsin - Madison
Postdoctoral Residency
University of Wisconsin - Madison
Complex Epilepsy; Ketogenic Diet
M.S.N.
St. Louis University
Pediatric Emergency Medicine
Developmental Disorders, Autism Spectrum Disorders, Motor Impairment
Pediatric Kidney Transplant, with an interest in developing a transitional program for adolescents moving to adult care providers.
Dr. Wilson seeks to develop tools that more accurately predict the responsiveness to immune therapy in autoimmune diseases and organ transplantation. His previous research uncovered how immune metabolism can contribute to immune tolerance in both Type 1 diabetes and lupus animal models. These findings form the basis for his current research which aims to utilize high-dimensional cytometry Spectral Flow Cytometry to detect changes in immune cell subsets in animal models and human patients with Type 1 diabetes and compare them to healthy controls and those treated with immune-targeting therapies (such as Teplizumab or Rituximab).
As he develops these tools for clinical application, he is continuing to develop flow cytometry-based tools in animal models to interrogate cell metabolism. He hopes that these tools will permit robust interrogation of alterations in metabolism on a single cell level in autoimmunity and in response to immune therapy. To this end, he is applying single cell metabolic tools like SCENITH, detection of rate-limiting metabolic proteins, and measurement of cell glycosylation using multicolor lectin panels in animal models of autoimmunity. He hopes these tools can be utilized clinically to predict responsiveness to immune therapy and elucidate mechanistic underpinnings of autoimmune pathogenesis and therapeutic responses.
Dr. Wilson has been funded by the National Institutes of Health and the Juvenile Diabetes Research Foundation. He serves as co-mentor of the ASPIRE Path in Molecular Medicine at Vanderbilt. His work has been presented and received awards at scientific sessions of the Immunology of Diabetes Society Congress and Southeastern Immunology Symposium. In 2018 Dr. Wilson was recognized as Vanderbilt Scholar in Diabetes.
Ph.D.
Microbiology and Immunology - Vanderbilt University School of Medicine